AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 35221104 — intervention group
Group type: EXPERIMENTAL
Intervention: Very early invasive coronary angiography (ICA)
Number of subjects: 2147
Study 35221104 — intervention group
Group type: COMPARATOR
Intervention: Standard care (ICA within 48 to 72 hours)
Number of subjects: 2147
Study 32628436 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaccinated group
Number of subjects: 494
Study 32628436 — intervention group
Group type: COMPARATOR
Intervention: Unvaccinated group
Number of subjects: 494
Study 32628436 — intervention group
Group type: EXPERIMENTAL
Intervention: Regular follow-ups
Number of subjects: 494
Study 32628436 — intervention group
Group type: EXPERIMENTAL
Intervention: Knowledge about tetanus vaccine
Number of subjects: 494
Study 36078842 — intervention group
Group type: EXPERIMENTAL
Intervention: PIVC pack
Number of subjects: 0
Study 33657976 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiloride/HCTZ
Number of subjects: 10
Study 33657976 — intervention group
Group type: COMPARATOR
Intervention: HCTZ
Number of subjects: 10
Study 32645111 — intervention group
Group type: EXPERIMENTAL
Intervention: Chest-press resistance training (using Smith machine, dumbbells, or Swiss ball)
Number of subjects: 35
Study 36058618 — intervention group
Group type: EXPERIMENTAL
Intervention: Postmastectomy radiation therapy (RT) with internal mammary nodal irradiation
Number of subjects: 26
Study 36058618 — intervention group
Group type: COMPARATOR
Intervention: Postmastectomy radiation therapy (RT) without internal mammary nodal irradiation
Number of subjects: 26
Study 36058618 — intervention group
Group type: EXPERIMENTAL
Intervention: Slice-by-slice analysis of CTVsc + axIII + axII
Number of subjects: 26
Study 36442021 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational Interviewing (MI)
Number of subjects: 164
Study 33400963 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum urate (observational analysis)
Number of subjects: 359827
Study 33400963 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum urate (2-stage MR analysis)
Number of subjects: 359827
Study 33400963 — intervention group
Group type: EXPERIMENTAL
Intervention: Serum urate (2-sample MR analysis)
Number of subjects: 359827
Study 34407046 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrotinib plus capecitabine
Number of subjects: 20
Study 34407046 — intervention group
Group type: COMPARATOR
Intervention: Capecitabine-only
Number of subjects: 20
Study 33293047 — intervention group
Group type: EXPERIMENTAL
Intervention: ICB with ultrasound guidance
Number of subjects: 160
Study 33293047 — intervention group
Group type: COMPARATOR
Intervention: No Ultrasound guidance
Number of subjects: 160
Study 35717357 — intervention group
Group type: EXPERIMENTAL
Intervention: Venastent
Number of subjects: 256
Study 35717357 — intervention group
Group type: COMPARATOR
Intervention: Zilver stent
Number of subjects: 256
Study 33002633 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT-based optimizing expectations (EXPECT)
Number of subjects: 124
Study 33002633 — intervention group
Group type: EXPERIMENTAL
Intervention: Active control group focusing on emotional support (SUPPORT)
Number of subjects: 124
Study 33002633 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care only (SMC)
Number of subjects: 124
Study 34120694 — intervention group
Group type: EXPERIMENTAL
Intervention: Video-based patient education
Number of subjects: 89
Study 34120694 — intervention group
Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 89
Study 32981178 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased BMI
Number of subjects: 647
Study 32981178 — intervention group
Group type: EXPERIMENTAL
Intervention: Obesity
Number of subjects: 647
Study 36163843 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral-AZA 300mg once-daily for 14 days/28-day cycle
Number of subjects: 472
Study 36163843 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 472
Study 36163843 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral-AZA
Number of subjects: 472
Study 36163843 — intervention group
Group type: COMPARATOR
Intervention: Non-LT survivors
Number of subjects: 472
Study 34178834 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 50,000 IU intramuscularly monthly for six months
Number of subjects: 0
Study 34178834 — intervention group
Group type: COMPARATOR
Intervention: Distilled water (0.25 mL) monthly for six months (Control)
Number of subjects: 0
Study 34178834 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 treatment group after 6 months of stopping treatment
Number of subjects: 0
Study 34528871 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 25
Study 32113648 — intervention group
Group type: EXPERIMENTAL
Intervention: Apolipoprotein A-I (apoA-I) concentrations
Number of subjects: 20370
Study 32113648 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetic variant rs12225230
Number of subjects: 20370
Study 32113648 — intervention group
Group type: EXPERIMENTAL
Intervention: ApoA-I concentrations (Mendelian randomization)
Number of subjects: 20370
Study 33884938 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiofrequency ablation of markedly incompetent perforators (Group A)
Number of subjects: 119
Study 33884938 — intervention group
Group type: COMPARATOR
Intervention: Conventional compression therapy (Group B)
Number of subjects: 119
Study 32332669 — intervention group
Group type: EXPERIMENTAL
Intervention: Adductor canal block (ACB)
Number of subjects: 120
Study 32332669 — intervention group
Group type: COMPARATOR
Intervention: Periarticular infiltration (PAI)
Number of subjects: 120
Study 33806616 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to PM2.5 PAHs in schools within 5 km of the petrochemical industry
Number of subjects: 205
Study 33806616 — intervention group
Group type: COMPARATOR
Intervention: Comparative population (children living more than 20 km away from industrial activity)
Number of subjects: 205
Study 32471186 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin E-bonded membranes (VEM)
Number of subjects: 80
Study 32471186 — intervention group
Group type: COMPARATOR
Intervention: High-flux same-surface polysulfone dialyzers (Control)
Number of subjects: 80
Study 35262417 — intervention group
Group type: EXPERIMENTAL
Intervention: Video group (intervention) - practiced skills on the robot simulator with intermediate video revision
Number of subjects: 40
Study 35262417 — intervention group
Group type: COMPARATOR
Intervention: Control group (control) - had intermediate pause instead of video revision
Number of subjects: 40
Study 35262417 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (video and control) on the da Vinci robot
Number of subjects: 40
Study 32826657 — intervention group
Group type: EXPERIMENTAL
Intervention: Tofacitinib 5 or 10 mg twice daily
Number of subjects: 7061
Study 32375655 — intervention group
Group type: EXPERIMENTAL
Intervention: Distinct episodes of axial pain separated by more than 6 months
Number of subjects: 539
Study 32375655 — intervention group
Group type: EXPERIMENTAL
Intervention: Axial pain with tendon symptoms within the same year
Number of subjects: 539
Study 32375655 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-occurrence of axial pain and a prescription for nonsteroidal anti-inflammatory drug within 30 days
Number of subjects: 539
Study 32375655 — intervention group
Group type: EXPERIMENTAL
Intervention: Coded episodes of axial pain
Number of subjects: 539
Study 32375655 — intervention group
Group type: EXPERIMENTAL
Intervention: Large joint symptoms and enthesopathy
Number of subjects: 539
Study 35917265 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradermal Botulinum toxin A injection
Number of subjects: 24
Study 35917265 — intervention group
Group type: COMPARATOR
Intervention: Topical 2% glycopyrrolate
Number of subjects: 24
Study 36253825 — intervention group
Group type: EXPERIMENTAL
Intervention: Gene-corrected autologous keratinocyte grafts (EB-101)
Number of subjects: 7
Study 32578689 — intervention group
Group type: EXPERIMENTAL
Intervention: Comprehensive multimodal prophylactic intervention for 2 years
Number of subjects: 0
Study 32578689 — intervention group
Group type: EXPERIMENTAL
Intervention: Early, consistent intervention after an initial manic episode
Number of subjects: 0
Study 33009844 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetes Education Program based on Tailored interventions and Theory of Planned Behaviour
Number of subjects: 436
Study 33009844 — intervention group
Group type: COMPARATOR
Intervention: Usual care (Control)
Number of subjects: 436
Study 34370064 — intervention group
Group type: EXPERIMENTAL
Intervention: Donepezil
Number of subjects: 30
Study 34370064 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 36005859 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 414
Study 36005859 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline IGF1
Number of subjects: 414
Study 36005859 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline IGFBP1
Number of subjects: 414
Study 34456752 — intervention group
Group type: EXPERIMENTAL
Intervention: Eccentric resistance exercise (10 sets of 5 eccentric unilateral repetitions at 80% of the pre‐determined concentric one repetition maximum)
Number of subjects: 29
Study 34456752 — intervention group
Group type: COMPARATOR
Intervention: Seated rest (No‐Ex)
Number of subjects: 29
Study 33930431 — intervention group
Group type: EXPERIMENTAL
Intervention: Heated tobacco products (HTPs)
Number of subjects: 2038
Study 33930431 — intervention group
Group type: EXPERIMENTAL
Intervention: E-cigarettes
Number of subjects: 2038
Study 33930431 — intervention group
Group type: EXPERIMENTAL
Intervention: Products without nicotine
Number of subjects: 2038
Study 33930431 — intervention group
Group type: EXPERIMENTAL
Intervention: Flavored products
Number of subjects: 2038
Study 32871985 — intervention group
Group type: EXPERIMENTAL
Intervention: Basic acupuncture and the herbal formulation dangui yinzi
Number of subjects: 111
Study 32871985 — intervention group
Group type: EXPERIMENTAL
Intervention: Danggui yinzi and shu‐stream acupuncture
Number of subjects: 111
Study 32871985 — intervention group
Group type: COMPARATOR
Intervention: Danggui yinzi alone
Number of subjects: 111
Study 33576844 — intervention group
Group type: EXPERIMENTAL
Intervention: Cod (750 g/week)
Number of subjects: 63
Study 33576844 — intervention group
Group type: EXPERIMENTAL
Intervention: Salmon (750 g/week)
Number of subjects: 63
Study 33576844 — intervention group
Group type: COMPARATOR
Intervention: Control (normal eating habits, no fish)
Number of subjects: 63
Study 32450908 — intervention group
Group type: EXPERIMENTAL
Intervention: Bujing Yishi tablets (BJYSP)
Number of subjects: 216
Study 32450908 — intervention group
Group type: COMPARATOR
Intervention: Mecobalamin tablets (Control)
Number of subjects: 216
Study 35511153 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fascial plane block targeting the superior gluteal nerve
Number of subjects: 0
Study 33621613 — intervention group
Group type: EXPERIMENTAL
Intervention: Goals to increase fruit and vegetable intake
Number of subjects: 203
Study 33621613 — intervention group
Group type: EXPERIMENTAL
Intervention: Goals to decrease unhealthy snack intake
Number of subjects: 203
Study 33621613 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 203
Study 32160301 — intervention group
Group type: EXPERIMENTAL
Intervention: H. P. Acthar gel (repository corticotropin injection)
Number of subjects: 8
Study 32160301 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 8
Study 35932354 — intervention group
Group type: EXPERIMENTAL
Intervention: Greater social support
Number of subjects: 1944
Study 35932354 — intervention group
Group type: EXPERIMENTAL
Intervention: Perceived stress
Number of subjects: 1944
Study 35932354 — intervention group
Group type: EXPERIMENTAL
Intervention: Unmet social needs
Number of subjects: 1944
Study 35932354 — intervention group
Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 1944
Study 32489675 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Intervention for Loneliness (PAIL) - once-weekly group walk and health education workshop up to 90 min per session for 12 weeks.
Number of subjects: 48
Study 32489675 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed control group (WL) - no intervention during the study period.
Number of subjects: 48
Study 32489675 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity Intervention for Loneliness (PAIL)
Number of subjects: 48
Study 32489675 — intervention group
Group type: COMPARATOR
Intervention: Wait-listed control group (WL)
Number of subjects: 48
Study 32489675 — intervention group
Group type: EXPERIMENTAL
Intervention: Focus group evaluations
Number of subjects: 48
Study 35069013 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmented Mindfulness-Based Cognitive Therapy (MBCT) combined with pharmacotherapy
Number of subjects: 160
Study 35069013 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment dominated by pharmacotherapy (Control group)
Number of subjects: 160
Study 33720857 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized balance games from the GAmification for Better LifE (GABLE) platform
Number of subjects: 25
Study 33720857 — intervention group
Group type: COMPARATOR
Intervention: Nintendo Wii games using a handheld Wii Remote
Number of subjects: 25
Study 33284989 — intervention group
Group type: EXPERIMENTAL
Intervention: Contingent reinforcement plus usual smoking cessation care
Number of subjects: 1634
Study 33284989 — intervention group
Group type: EXPERIMENTAL
Intervention: More intensive behavioral smoking cessation support
Number of subjects: 1634
Study 33284989 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-issue support
Number of subjects: 1634
Study 33284989 — intervention group
Group type: EXPERIMENTAL
Intervention: Text-messaging support, e-cigarettes, cognitive behavioral therapy
Number of subjects: 1634
Study 36435990 — intervention group
Group type: EXPERIMENTAL
Intervention: Early peanut introduction from infancy
Number of subjects: 0
Study 32441198 — intervention group
Group type: EXPERIMENTAL
Intervention: Co-supplementation (50,000 IU vitamin D weekly + two omega-3 fatty acid capsules daily)
Number of subjects: 81
Study 32441198 — intervention group
Group type: EXPERIMENTAL
Intervention: Omega-3 fatty acid (two omega-3 fatty acid capsules daily + vitamin D placebo weekly)
Number of subjects: 81
Study 32441198 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (50,000 IU vitamin D weekly + omega-3 placebo daily)
Number of subjects: 81
Study 32441198 — intervention group
Group type: COMPARATOR
Intervention: Control (vitamin D placebo weekly + two omega-3 placebo capsules daily)
Number of subjects: 81
Study 33844054 — intervention group
Group type: EXPERIMENTAL
Intervention: Double plating (3.5 LCP and 2.7 LCP plate in 90–90 configuration)
Number of subjects: 12
Study 33844054 — intervention group
Group type: COMPARATOR
Intervention: Single plating (single 3.5 LCP plate)
Number of subjects: 12
Study 33844054 — intervention group
Group type: COMPARATOR
Intervention: All specimens (including 4 without osteoporotic BMD)
Number of subjects: 12
Study 33165586 — intervention group
Group type: EXPERIMENTAL
Intervention: In-service nutrition education and counselling package
Number of subjects: 20
Study 33165586 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 35042047 — intervention group
Group type: EXPERIMENTAL
Intervention: Intrapartum nipple stimulation therapy
Number of subjects: 24
Study 35042047 — intervention group
Group type: COMPARATOR
Intervention: Oxytocin infusion
Number of subjects: 24
Study 33161737 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus subtilis strain DE111
Number of subjects: 100
Study 33249273 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin (40 mg) + L-arginine (1.5 g)
Number of subjects: 15
Study 33249273 — intervention group
Group type: COMPARATOR
Intervention: Control (untreated)
Number of subjects: 15
Study 33244125 — intervention group
Group type: EXPERIMENTAL
Intervention: Pedagogical Questions
Number of subjects: 72
Study 33244125 — intervention group
Group type: EXPERIMENTAL
Intervention: Direct Instruction
Number of subjects: 72
Study 33244125 — intervention group
Group type: COMPARATOR
Intervention: Control content
Number of subjects: 72
Study 32701682 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthes 3.5‐mm LCP precontoured superior‐anterior clavicle plate (PCRP)
Number of subjects: 24
Study 32701682 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthes 3.5‐mm LCP reconstruction plate (RP)
Number of subjects: 24
Study 32701682 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthes 2.7‐mm cold‐worked calcaneal reconstruction plate with 6 bicortical screws (CRP6)
Number of subjects: 24
Study 32701682 — intervention group
Group type: EXPERIMENTAL
Intervention: Synthes 2.7‐mm cold‐worked calcaneal reconstruction plate with 8 bicortical screws (CRP8)
Number of subjects: 24
Study 34559686 — intervention group
Group type: EXPERIMENTAL
Intervention: Olive oil applied to abdomens twice a day
Number of subjects: 156
Study 34559686 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 156
Study 33218535 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular Mobilization (SM)
Number of subjects: 52
Study 33218535 — intervention group
Group type: EXPERIMENTAL
Intervention: Pectoralis Minor Stretching (PMS)
Number of subjects: 52
Study 33218535 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined Scapular Mobilization + Pectoralis Minor Stretching (SM + PMS)
Number of subjects: 52
Study 33218535 — intervention group
Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 52
Study 36110080 — intervention group
Group type: EXPERIMENTAL
Intervention: Mtwo root canal preparation method modified by Mtwo machine nickel‐titanium file
Number of subjects: 96
Study 36110080 — intervention group
Group type: COMPARATOR
Intervention: Modified Mtwo preparation method with synchronous root canal length measurement
Number of subjects: 96
Study 33317156 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium yeast (200 µg/day) and coenzyme Q10 (200 mg/day)
Number of subjects: 215
Study 33317156 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 215
Study 33317156 — intervention group
Group type: EXPERIMENTAL
Intervention: Selenium yeast and coenzyme Q10
Number of subjects: 215
Study 33161458 — intervention group
Group type: EXPERIMENTAL
Intervention: Project MIND training with a strong emphasis on role playing and skills rehearsal
Number of subjects: 18
Study 33161458 — intervention group
Group type: EXPERIMENTAL
Intervention: Highly structured supervision and debriefing provided by a registered counsellor
Number of subjects: 18
Study 33161458 — intervention group
Group type: EXPERIMENTAL
Intervention: Providing mental health counselling in primary healthcare
Number of subjects: 18
Study 33031846 — intervention group
Group type: EXPERIMENTAL
Intervention: Proton beam radiotherapy (PBT)
Number of subjects: 144
Study 33031846 — intervention group
Group type: COMPARATOR
Intervention: Radiofrequency ablation (RFA)
Number of subjects: 144
Study 32034072 — intervention group
Group type: EXPERIMENTAL
Intervention: Rindopepimut with bevacizumab
Number of subjects: 73
Study 32034072 — intervention group
Group type: COMPARATOR
Intervention: Control (keyhole limpet hemocyanin) with bevacizumab
Number of subjects: 73
Study 33630453 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraperitoneal Local Anesthetic (IPL)
Number of subjects: 56
Study 33630453 — intervention group
Group type: COMPARATOR
Intervention: Intravenous Local Anesthetic (IVL)
Number of subjects: 56
Study 34474314 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based exercise program (10 weeks)
Number of subjects: 20
Study 34474314 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 20
Study 36148741 — intervention group
Group type: EXPERIMENTAL
Intervention: EPA supplementation (3 g/day)
Number of subjects: 28
Study 36148741 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA supplementation (3 g/day)
Number of subjects: 28
Study 36148741 — intervention group
Group type: COMPARATOR
Intervention: Olive oil control
Number of subjects: 28
Study 32843251 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonextraction therapy
Number of subjects: 57
Study 32843251 — intervention group
Group type: COMPARATOR
Intervention: Extraction of 4 first premolars
Number of subjects: 57
Study 36305926 — intervention group
Group type: EXPERIMENTAL
Intervention: Acellular Dermal Matrix (ADM) + Modified Coronally Advanced Tunnel Technique (MCAT)
Number of subjects: 24
Study 36305926 — intervention group
Group type: COMPARATOR
Intervention: Subepithelial Connective Tissue Graft (SCTG) + Modified Coronally Advanced Tunnel Technique (MCAT)
Number of subjects: 24
Study 36305926 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient satisfaction with esthetic outcome
Number of subjects: 24
Study 34800099 — intervention group
Group type: EXPERIMENTAL
Intervention: Handheld fan used for 14 days
Number of subjects: 96
Study 32917261 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest model for predicting acute myocardial infarction (AMI) < 1 month
Number of subjects: 85254
Study 32917261 — intervention group
Group type: EXPERIMENTAL
Intervention: Random forest model for predicting all-cause mortality < 1 month
Number of subjects: 85254
Study 32917261 — intervention group
Group type: EXPERIMENTAL
Intervention: AI prediction model validation with new patients for AMI < 1 month
Number of subjects: 85254
Study 32917261 — intervention group
Group type: EXPERIMENTAL
Intervention: AI prediction model validation with new patients for all-cause mortality < 1 month
Number of subjects: 85254
Study 32917261 — intervention group
Group type: COMPARATOR
Intervention: Comparative predictive accuracy of random forest model
Number of subjects: 85254
Study 34435812 — intervention group
Group type: EXPERIMENTAL
Intervention: Asylum Seekers Photographic Interview (ASPI)
Number of subjects: 36
Study 34435812 — intervention group
Group type: COMPARATOR
Intervention: Non-image-mediated narrative interview (Control)
Number of subjects: 36
Study 33686879 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcrystalline paclitaxel-coated balloon (mcPCB)
Number of subjects: 66
Study 32448345 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenously administered remdesivir for 10 days
Number of subjects: 0
Study 32448345 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 10 days
Number of subjects: 0
Study 36058795 — intervention group
Group type: EXPERIMENTAL
Intervention: CCHFV vaccine trial designed to capture infection as a trial endpoint
Number of subjects: 150
Study 36058795 — intervention group
Group type: EXPERIMENTAL
Intervention: CCHFV vaccine trial designed to capture clinical case as a trial endpoint
Number of subjects: 150